Literature DB >> 32663526

Ubiquitin ligase Cbl-b and inhibitory Cblin peptides.

Takeshi Nikawa1, Kazumi Ishidoh2.   

Abstract

This review focuses on the Cbl-b muscle atrophy-associated ubiquitin ligase and its inhibitors. Herein, the role of E3 ubiquitin ligase-associated muscle atrophy genes (atrogenes), including MAFbx-1/agrogin-1 and MuRF-1, as well as another ubiquitin ligase, Cbl-b and its inhibitors, is discussed. Cbl-b plays an important role in unloading muscle atrophy caused by spaceflight and in bedridden patients: Cbl-b ubiquitinated and induced the degradation of IRS-1, a key intermediate in the IGF-1 signaling. Furthermore, a pentapetpide (DGpYMP), inhibited Cbl-b-mediated IRS-1 ubiquitination. This peptide-based Cbl-b inhibitor Cblin and its homologous peptides in foods presumably affect muscle atrophy under such conditions.
Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cbl-b; Cblin; MAFbx-1/atrogin-1; MuRF-1; Muscle atrophy

Mesh:

Substances:

Year:  2020        PMID: 32663526     DOI: 10.1016/j.bbapap.2020.140495

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  3 in total

1.  Novel Lactams as Cbl-b Inhibitors for Treating Cancer.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-09-23       Impact factor: 4.632

2.  miR-27b-3p Attenuates Muscle Atrophy by Targeting Cbl-b in Skeletal Muscles.

Authors:  Xin Yang; Zhenhui Li; Zhijun Wang; Jiaao Yu; Manting Ma; Qinghua Nie
Journal:  Biomolecules       Date:  2022-01-23

3.  Muscle transcriptome provides the first insight into the dynamics of gene expression with progression of age in sheep.

Authors:  Reena Arora; Naveen Kumar Siddaraju; S S Manjunatha; S Sudarshan; Mohamed Nadeem Fairoze; Ashish Kumar; Pooja Chhabra; Mandeep Kaur; R M Sreesujatha; Sonika Ahlawat; Ramesh Kumar Vijh
Journal:  Sci Rep       Date:  2021-11-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.